Literature DB >> 1288301

T cell-mediated inhibition of erythropoiesis in myelodysplastic syndromes.

T Sugawara, K Endo, T Shishido, A Sato, J Kameoka, O Fukuhara, K Yoshinaga, A Miura.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1288301     DOI： 10.1002/ajh.2830410425

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  Treatment of myelodysplastic syndrome with cyclosporin A.

Authors:  Shuchang Chen; Bin Jiang; Wanming Da; Ming Gong; Mei Guan
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

2.  Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.

Authors:  Ayami Yoshimi; Marry M van den Heuvel-Eibrink; Irith Baumann; Stephan Schwarz; Ingrid Simonitsch-Klupp; Pascale de Paepe; Vit Campr; Gitte Birk Kerndrup; Maureen O'Sullivan; Rita Devito; Roos Leguit; Miguel Hernandez; Michael Dworzak; Barbara de Moerloose; Jan Stary; Henrik Hasle; Owen P Smith; Marco Zecca; Albert Catala; Markus Schmugge; Franco Locatelli; Monika Führer; Alexandra Fischer; Anne Guderle; Peter Nöllke; Brigitte Strahm; Charlotte M Niemeyer
Journal:  Haematologica       Date:  2013-10-25       Impact factor: 9.941

3.  Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome.

Authors:  Paulo V Campregher; Santosh K Srivastava; H Joachim Deeg; Harlan S Robins; Edus H Warren
Journal:  Exp Hematol       Date:  2009-12-24       Impact factor: 3.084
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.